New Medicare Negotiation List Spotlights Small Molecule Liability For Cancer Drugs

 
• By Cathy Kelly
  
Oral drugs have a shorter period of unfettered pricing. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Medicare

More from Government Payers